Solution structure of peptides from HIV-1 Vpr protein that cause membrane permeabilization and growth arrest (original) (raw)
A Cell-penetrating Helical Peptide as a Potential HIV-1 Inhibitor
Xiaohe Tong
Journal of Molecular Biology, 2008
View PDFchevron_right
Conformation of the HIV-1 Gag Protein in Solution
Siddhartha Datta
Journal of Molecular Biology, 2007
View PDFchevron_right
An extended CCR5-ECL2 peptide forms a helix that binds HIV-1 gp120 through non-specific hydrophobic interactions
Fred Naider
FEBS Journal, 2015
View PDFchevron_right
HIV-1 Replication Is Inhibited by a Pseudo-substrate Peptide That Blocks Tat Transactivation
Takashi Okamoto
Virology, 2000
View PDFchevron_right
Three-Dimensional Structure of HIV-1 Rev Protein Filaments
Benes Trus
Journal of Structural Biology, 1998
View PDFchevron_right
Anti-HIV Activity of Multibranched Peptide Constructs Derived either from the Cleavage Sequence or from the Transmembrane Domain (gp41) of the Human Immunodeficiency Virus Type 1 Envelope
kamel mabrouk
Virology, 1996
View PDFchevron_right
Effect of E1(64–81) hepatitis G peptide on the in vitro interaction of HIV-1 fusion peptide with membrane models
Ma Antònia Busquets
Biochimica et Biophysica Acta (BBA) - Biomembranes, 2011
View PDFchevron_right
Molecular Dynamics Simulations Reveal the HIV-1 Vpu Transmembrane Protein to Form Stable Pentamers
Nabab Khan
PLoS ONE, 2013
View PDFchevron_right
Cytopathic Mechanisms of HIV-1
Joshua Costin
Virology Journal, 2007
View PDFchevron_right
Interaction between HIV1 Rev and Integrase Proteins: A BASIS FOR THE DEVELOPMENT OF ANTI-HIV PEPTIDES
Abraham Loyter
Journal of Biological Chemistry, 2007
View PDFchevron_right
Concentration-dependent differential induction of necrosis or apoptosis by HIV-1 lytic peptide 1
Joshua Costin
Peptides, 1999
View PDFchevron_right
Multibranched V3 peptides inhibit human immunodeficiency virus infection in human lymphocytes and macrophages
kamel mabrouk
Peptides 1994, 1995
View PDFchevron_right
Antiviral agent based on the non-structural protein targeting the maturation process of HIV-1: expression and susceptibility of chimeric Vpr as a substrate for cleavage by HIV-1 protease
Robert Harrison
Protein Engineering Design and Selection, 2000
View PDFchevron_right
Exposed Hydrophobic Residues in Human Immunodeficiency Virus Type 1 Vpr Helix-1 Are Important for Cell Cycle Arrest and Cell Death
Ralph Tripp
Plos One, 2011
View PDFchevron_right
Membrane Potential Depolarization as a Triggering Mechanism for Vpu-Mediated HIV-1 Release
Krekwit Shinlapawittayatorn
Biophysical Journal, 2010
View PDFchevron_right
Physical interaction of the HIV-1 Nef protein with beta-COP, a component of non-clathrin-coated vesicles essential for membrane traffic
Jacques Camonis
Journal of Biological Chemistry, 1994
View PDFchevron_right
HIV-1 entry – an expanding portal for drug discovery
Nicholas Meanwell
Drug Discovery Today, 2000
View PDFchevron_right
A GxxxG-like Motif within HIV-1 Fusion Peptide Is Critical to Its Immunosuppressant Activity, Structure, and Interaction with the Transmembrane Domain of the T-cell Receptor
Omri Faingold
Journal of Biological Chemistry, 2012
View PDFchevron_right
High-resolution structure of an HIV-1 quasispecies
A. Meyerhans
AIDS, 1992
View PDFchevron_right
A Binding Pocket for a Small Molecule Inhibitor of HIV-1 Entry Within the Transmembrane Helices of CCR5
Steven Lin X
Proceedings of the …, 2000
View PDFchevron_right
Activation of gp120 of human immunodeficiency virus by their V3 loop-derived peptides
俊夫 服部
Biochemical and Biophysical Research Communications, 2002
View PDFchevron_right
Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry function
Ben Berkhout
Virology, 2010
View PDFchevron_right
HIV-1 envelope facilitates the development of protease inhibitor resistance through acquiring mutations associated with viral entry and immune escape
khe maphumulo
Frontiers in microbiology, 2024
View PDFchevron_right
Polarity Changes in the Transmembrane Domain Core of HIV-1 Vpu Inhibits Its Anti-Tetherin Activity
Ralph Tripp
2011
View PDFchevron_right
Modification of FP-HIV activity by peptide sequences of GB virus C: A biophysical approach
Victoria Girona
Biochimica Et Biophysica Acta-Biomembranes, 2014
View PDFchevron_right
Structure-activity relationship study of the plasma membrane translocating potential of a short peptide from HIV-1 Tat protein
Bernard Lebleu
Letters in Peptide Science, 1997
View PDFchevron_right
Designing of novel antigenic peptide cocktail for the detection of antibodies to HIV-1/2 by ELISA
Ram Pramod Tiwari
Journal of Immunological Methods, 2013
View PDFchevron_right
Broad activation of latent HIV-1 in vivo
Ole Søgaard
Nature Communications, 2016
View PDFchevron_right
Viroporin potential of the lentivirus lytic peptide (LLP) domains of the HIV-1 gp41 protein
Joshua Costin
Virology Journal, 2007
View PDFchevron_right
Stabilized HIV-1 Envelope Glycoprotein Trimers Lacking the V1V2 Domain, Obtained by Virus Evolution
Ben Berkhout
Journal of Biological Chemistry, 2010
View PDFchevron_right
The membranes’ role in the HIV-1 neutralizing monoclonal antibody 2F5 mode of action needs re-evaluation
ana licia veiga
Antiviral Research, 2006
View PDFchevron_right
Evidence for a cytopathogenicity determinant in HIV-1 Vpr
Beda Brichacek
Proceedings of the National Academy of Sciences of the United States of America, 2002
View PDFchevron_right
Helix-Loop-Helix Motif in HIV-1 Rev
Hubert Gstach
Biochemistry, 1994
View PDFchevron_right
HIV-1 tolerates changes in A-count in a small segment of the pol gene
Ben Berkhout
Retrovirology
View PDFchevron_right
Protein Promiscuity: Drug Resistance and Native Functions—HIV-1 Case
Ben Berkhout
Journal of Biomolecular Structure and Dynamics, 2005
View PDFchevron_right